Bibliographie (2546)
FDA approves antibiotic Zevtera (ceftobiprole medocaril sodium) for three indications
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiThe FDA has granted approval for Zevtera (ceftobiprole medocaril sodium), an antibiotic formulated for injection, targeting three key bacterial infections. This includes treatment for adults with Staphylococcus aureus bloodstream infections (SAB) with or without right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSI), and community-acquired bacterial pneumonia (CABP) in both adults and pediatric […]
The post FDA approves antibiotic Zevtera (ceftobiprole medocaril sodium) for three indications appeared first on Links Medicus.
Cohort Study: Inappropriate pneumonia diagnoses and associated risks in 17,290 hospitalized adults
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: This prospective cohort study analyzed medical records and patient interactions from July 2017 to March 2020 across 48 Michigan hospitals. A total of 17,290 adults admitted for general care were retrospectively assessed for community-acquired pneumonia (CAP) treatment, focusing on those who received antibiotics within the first two days of hospitalization. […]
The post Cohort Study: Inappropriate pneumonia diagnoses and associated risks in 17,290 hospitalized adults appeared first on Links Medicus.
RCT: Bisoprolol Does Not Reduce COPD Exacerbations in High-Risk Patients – JAMA
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: The Bisoprolol in COPD Study (BICS) was a double-blind, placebo-controlled randomized clinical trial conducted across 76 sites in the UK, including both primary and secondary care clinics. The study enrolled 515 patients with chronic obstructive pulmonary disease (COPD) who had moderate to severe airflow obstruction and a history of at least […]
The post RCT: Bisoprolol Does Not Reduce COPD Exacerbations in High-Risk Patients – JAMA appeared first on Links Medicus.
Meta-Analysis: Inhaled Antibiotics Offer Modest Reductions in Exacerbations and Quality of Life Gains in Bronchiectasis – CHEST
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: This study is an updated systematic review and meta-analysis of 20 randomized controlled trials involving 3,468 adults with bronchiectasis, who were treated with inhaled antibiotics. The trials included in the analysis were selected based on criteria such as a minimum treatment duration of 4 weeks and involved patients diagnosed by CT […]
The post Meta-Analysis: Inhaled Antibiotics Offer Modest Reductions in Exacerbations and Quality of Life Gains in Bronchiectasis – CHEST appeared first on Links Medicus.
Randomized Trials: Tirzepatide Reduces Apnea-Hypopnea Index and Body Weight in Patients with Obstructive Sleep Apnea and Obesity – N Engl J Med
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: This study comprises two phase 3, double-blind, randomized trials involving adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. Participants were either using or not using positive airway pressure (PAP) therapy at baseline and received tirzepatide or placebo over 52 weeks. Main Findings: Tirzepatide significantly reduced the apnea-hypopnea index (AHI) by […]
The post Randomized Trials: Tirzepatide Reduces Apnea-Hypopnea Index and Body Weight in Patients with Obstructive Sleep Apnea and Obesity – N Engl J Med appeared first on Links Medicus.
RCT: Pantoprazole Reduces GI Bleeding in Mechanically Ventilated ICU Patients – N Engl J Med
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: This international, randomized, double-blind trial involved 4,821 critically ill adults undergoing invasive mechanical ventilation across 68 intensive care units (ICUs). Participants were assigned to receive either intravenous pantoprazole (40 mg daily) or a matching placebo. The primary efficacy outcome was the incidence of clinically significant upper gastrointestinal bleeding within 90 days, […]
The post RCT: Pantoprazole Reduces GI Bleeding in Mechanically Ventilated ICU Patients – N Engl J Med appeared first on Links Medicus.
Meta-Analysis: Effects of extracorporeal CO2 removal on gas exchange and ventilator settings in critically ill adults – Crit Care
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiSummary: Study Design and Population: This systematic review and meta-analysis included 49 studies (3 RCTs, 46 observational studies) involving 1672 critically ill adults undergoing extracorporeal carbon dioxide removal (ECCO2R) for respiratory failure between January 2000 and March 2022. Main Findings: ECCO2R significantly reduced PaCO2, plateau pressure, and tidal volume, while increasing pH across all patient […]
The post Meta-Analysis: Effects of extracorporeal CO2 removal on gas exchange and ventilator settings in critically ill adults – Crit Care appeared first on Links Medicus.
Innovative Antimicrobial Susceptibility Testing Bypasses Blood Culture, Promising Faster Sepsis Diagnosis – Nature
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: This study introduces a novel ultra-rapid antimicrobial susceptibility testing (AST) method that bypasses the traditional blood culture process, potentially reducing diagnostic time by 40-60 hours. The method was evaluated using a cohort of 190 hospitalized patients in Korea with suspected sepsis, including those with blood cancers. Main Findings: The new AST […]
The post Innovative Antimicrobial Susceptibility Testing Bypasses Blood Culture, Promising Faster Sepsis Diagnosis – Nature appeared first on Links Medicus.
Review: Prevention and Management of Device-Associated Complications in the Intensive Care Unit – The BMJ
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiIntroduction: This review article, published by experts from the David Geffen School of Medicine at UCLA, focuses on the complications associated with invasive devices commonly used in the Intensive Care Unit (ICU). While these devices are essential for managing critically ill patients, they also pose significant risks, necessitating a thorough understanding of their potential complications […]
The post Review: Prevention and Management of Device-Associated Complications in the Intensive Care Unit – The BMJ appeared first on Links Medicus.
RCT: Osimertinib Significantly Extends Progression-Free Survival in Unresectable Stage III EGFR-Mutated NSCLC After Chemoradiotherapy – N Engl J Med
samedi, 14 septembre 2024 05:28 Écrit par Zouhair SouissiStudy Design and Population: This phase 3, double-blind, placebo-controlled trial enrolled 216 patients with unresectable stage III EGFR-mutated non-small-cell lung cancer (NSCLC) who showed no disease progression during or after chemoradiotherapy. Patients were randomly assigned to receive either osimertinib (143 patients) or a placebo (73 patients) until disease progression. Main Findings: The study found that […]
The post RCT: Osimertinib Significantly Extends Progression-Free Survival in Unresectable Stage III EGFR-Mutated NSCLC After Chemoradiotherapy – N Engl J Med appeared first on Links Medicus.
